Senseonics (NYSE:SENS) has offered some insight into its plans for its next-generation implantable continuous glucose ...

“Inhaled insulin can quickly get to the carbohydrates that are in the bloodstream, get them into the cells and out of the ...

(Nasdaq:MODD) has shared new data highlighting the use of its insulin pump technology to deliver GLP-1 therapeutics.

The system — similar to continuous glucose monitoring (CGM) uses a new method of continuously sensing specific chemistry ...

Additionally, Insulet shared that it has two planned clinical trials for new algorithms for its platforms. One involves ...

LifePlus announced the clinical validation of its non-invasive and cuffless wearable for continuous glucose and blood ...

BTIG analysts said today that MiniMed, the Medtronic diabetes business, has some significant pipeline updates.

While many systems already pair continuous glucose monitors (CGMs) and insulin pumps, PharmaSens and SiBionics may have ...

BTIG analysts said today that Beta Bionics expects to launch a new insulin patch pump system in the U.S. by the end of 2027.

For many, a partnership between Abbott and Medtronic, two medtech giants and frequent competitors, would have seemed unlikely ...

Vaxess Technologies today shared new preclinical data highlighting the capability of its drug delivery patch to deliver ...

(Nasdaq:GCTK) believes it can tap into a diabetes market that includes millions of people who aren't being served completely.